SOSEI CO LTD has a total of 33 patent applications. Its first patent ever was published in 1999. It filed its patents most often in United Kingdom, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are BAJER KHEL SKER AG, SULFATEQ B V and SHIRE MOVETIS N V.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Australia | 4 | |
#4 | EPO (European Patent Office) | 4 | |
#5 | Canada | 3 | |
#6 | Republic of Korea | 3 | |
#7 | United States | 2 | |
#8 | Brazil | 1 | |
#9 | China | 1 | |
#10 | Hong Kong | 1 | |
#11 | Israel | 1 | |
#12 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Environmental technology | |
#5 | Basic materials chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Koseki Chizuko | 7 |
#2 | Ono Takashi | 7 |
#3 | Treherne Johnathan Mark | 7 |
#4 | Dixon Alistair Kerr | 7 |
#5 | Shinya Kazuo | 6 |
#6 | Morohoshi Toshiro | 6 |
#7 | Zhao Fei-Yeu | 6 |
#8 | Tauchi Tetsuzo | 6 |
#9 | Hekimi Siegfried | 4 |
#10 | Hihi Abdelmadjid K | 4 |
Publication | Filing date | Title |
---|---|---|
CA2669123A1 | Acat inhibitors and their use in the prevention or treatment of fibrosis | |
WO2008012546A2 | Azapeptides for use in therapy against interstitial cystitis | |
GB0516610D0 | Compounds for use in therapy | |
GB0515900D0 | Compounds for use in therapy | |
GB0512554D0 | Compounds for use in therapy | |
GB0510814D0 | Compounds for use in therapy | |
GB0510815D0 | Compounds for use in therapy | |
WO2005082054A2 | Combinations for the treatment of fungal infections | |
GB0427826D0 | Compounds for use in therapy | |
GB0423117D0 | Compounds for use in therapy | |
EP1602659A1 | Gm-95-containing antitumor effect potentiator, combined antitumor preparation and antitumor agent |